Active Psoriatic Arthritis Market Outlook 2020: Industry Trends, Analysis, Business Growth, Dynamics, Segmentation, Revenue and Forecast 2027

Research Reports

Jan 20, 2021

Market Size – USD 7.15 Billion in 2019, Market Growth – CAGR of 9.2%, Market Trends– Growing Prevalence of Psoriasis

Significant growth in incidences of active psoriatic arthritis is observed across emerging countries together with increasing elderly population. Also, poor standard of living due to stressful work-life balance resulting in the overstimulation of immune system. Rising advancements in biosimilars and robust pipeline of biologic products are expressively enhancing the availability of safe and efficient psoriatic arthritis treatment. High incidence of psoriatic arthritis is extensively experienced by those patients who are already suffering from plague psoriasis. These scenarios are actively contribute to the industry growth of active psoriatic arthritis treatment and therefore, demand for drugs linked with this treatment are also likely to escalate in the forecast period.

Active psoriatic arthritis and rheumatoid arthritis showcase more or less similar signs and symptoms of swollen joints and are unbearably painful and warm to touch. Consequently, possibilities of misdiagnosis are unfavorably high and is most likely to challenge the growth scenarios of the industry in the forecast period.

Factors likely to restrict the industry growth include high cost associated with treatments and target drugs along with stringent government rules and regulations. Moreover, research across the world suggests that patients suffering from active psoriatic arthritis are recorded to be significantly vulnerable to the ongoing COVIDâ€19 pandemic. Moreover, incapability to access required healthcare services and increasing burden of excessive stress is causing exacerbations in patients suffering from active psoriatic arthritis.

Browse the full report description @ https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market

Due to high emergence and employability of biologics and biosimilar products in potential treatment, biologics drug class segment accounted for the largest market share of approximately 39.8%. Moreover, traditional biologics have a capacity to improve complete immune system

Biologics and biosimilar products are mostly sold only on the basis of prescription. Prescription products segment in the products outlook accounted for the largest market revenue with a market share of approximately 47.5% in 2019

Existing market players operating in the industry have undertaken a number of strategies to propel in the market. Thus, in August 2019, Amgen and Bristol-Myers Squibb (BMS) announced to have acquired worldwide rights to Otezla (only oral non-biologic treatment for psoriasis and psoriatic arthritis) from Bristol-Myers Squibb’s merger partner Celgene

Emerging countries of Asia Pacific offer large number of patient pool as countries like India and China holds high population density along with high frequency of psoriatic arthritis especially in geriatric population. Asia Pacific registered noteworthy CAGR of 10.2% in 2019 and is expected to intensify its growth rate over the forecast period

Frequencies of active psoriatic arthritis symptoms are extensively high in those patients already suffering from psoriasis. The most widespread autoimmune disease in the United States is psoriasis affecting more than 7.5 to 8 million people every year.

Regional Scope- North America; Europe; Asia Pacific; Central & South America; MEA

For More Details Get FREE Sample Pages of this Research Report@ https://www.emergenresearch.com/request-sample-form/72

Key market players profiled for this industry analysis include Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies

Product Outlook (Revenue in Million USD; 2017–2027)

Prescriptions

OTC

Other

Drug Class Outlook (Revenue in Million USD; 2017–2027)

Biologics

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

Other

By Route of Administration (Revenue in Million USD; 2017–2027)

Injectable

Oral

Topical

Helping you establish a strong foothold in the industry

The Active Psoriatic Arthritis report highlights set of information related to pricing and the category of customers who are more than willing to pay for certain products and services. The information on opportunities as well as product features, determine which offerings or benefits command sale and identify the communications channels used by the market leaders to create premium positioning strategies as well as attract broadest share.

Browse the full report description @ https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market

The research provides answers to the following key questions:

What is the estimated size of the Active Psoriatic Arthritis market for the forecast period, 2020 – 2027? What will be the growth rate of the industry during the estimated period?

What are the prominent driving forces likely to impact the progress of the industry across different regions?

Who are the major market players occupying a strong foothold in the Active Psoriatic Arthritis market? What are the winning strategies adopted by them to stay ahead in the competition?

What are the potential opportunities for the Active Psoriatic Arthritis market for the forecast period, 2020 – 2027?

What are the key trends expected to shape the development of the industry over the coming years?

What are the key restraints and challenges likely to hinder the growth of the Active Psoriatic Arthritis market worldwide?

Thank you for reading our report. For further information or queries about the report or customization options, please get in touch with us. We will ensure your report is tailored according to your requirements.

Related Reports:

Signal Intelligence (SIGINT) Market to Reach USD 18.28 Billion By 2027 | Emergen Research

Sodium Dichromate Market To Be Worth USD 1,242.4 Million by 2027| Emergen Research

Industrial Microbiology Market To Be Worth USD 17.71 Billion by 2027| Emergen Research

Surgical Instrument Tracking Systems Market To Reach USD 431.6 Million by 2027| Emergen Research

Medical Lighting Technologies Market Size To Be Worth USD 2.99 Billion by 2027 | Emergen Research

Tags: Active Psoriatic Arthritis Market Recent Trends, Active Psoriatic Arthritis Market Importance, Active Psoriatic Arthritis Market Characteristics, Active Psoriatic Arthritis Market Revenue, Active Psoriatic Arthritis Market Forecasts, Active Psoriatic Arthritis Market Key Players, Active Psoriatic Arthritis Market Manufacturers, Active Psoriatic Arthritis Market Companies, Active Psoriatic Arthritis Market Product, Active Psoriatic Arthritis Market Research, Active Psoriatic Arthritis Market Opportunity, Active Psoriatic Arthritis Market Outlook, Active Psoriatic Arthritis Market Insights, Active Psoriatic Arthritis Market Segmentations, Active Psoriatic Arthritis Market Regions, Active Psoriatic Arthritis Market Applications, Active Psoriatic Arthritis Market Strategy, Active Psoriatic Arthritis Market Trends, Active Psoriatic Arthritis Market Overview, Active Psoriatic Arthritis Market Analysis, Active Psoriatic Arthritis Market Types, Active Psoriatic Arthritis Market Demand, Active Psoriatic Arthritis Market Growth, Active Psoriatic Arthritis Market Share, Active Psoriatic Arthritis Market Size See Campaign: http://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market
Contact Information:
Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: [email protected] Facebook | LinkdIn | Twitter | Blogs